Skip to Content

Reversal of Multidrug Resistance in Cancer

By John A. Kellen

Contributors: Catherine A. O'Brian, June L. Biedler, Dominic Fan, Barbara A. Spengler, James H. Goldie, Andrew J. Coldman, Gerald A. Hoeltge, Ram Ganapathi, Dale Grabowski, Alexander Lai, Pedro J. Beltran

Published December 6th 1993 by CRC Press – 160 pages

Purchasing Options:

Description

This critical, state-of-the-art review brings together the scattered and often controversial information on multidrug resistance reversal. Leading scientists in the field cover P-glycoprotein, the genetics of resistance, and its reversal by drugs. Resistance modifiers and modulators are tabulated and critically evaluated. Reversal of Multidrug Resistance in Cancer is important reading for oncologists, cancer chemotherapists, and other cancer researchers.

Contents

Preface (J.A. Kellen). The Phenomenon of Multidrug Resistance (J.A. Kellen). Collateral Sensitization in Multidrug Resistance (J.L. Biedler and B.A. Spengler). Cytogenetics of Multidrug Resistance (R. Ganapathi, D. Grabowski, and G. Hoeltge). Mathematical Models of Multidrug Resistance (J. Goldie, A.J. Coldman, and A. Lai). Multidrug Resistance in Human Malignancies (J.A. Kellen). Reversal of Multidrug Resistance (D. Fan, P.J. Beltran, and C.A. O'Brian). Outlook (J.A. Kellen and D. Fan). Conclusion (J.A. Kellen). Index.

Related Subjects

  1. Pharmacology
  2. Oncology

Name: Reversal of Multidrug Resistance in Cancer (Hardback) – CRC Press 
Description: By John A. KellenContributors: Catherine A. O'Brian, June L. Biedler, Dominic Fan, Barbara A. Spengler, James H. Goldie, Andrew J. Coldman, Gerald A. Hoeltge, Ram Ganapathi, Dale Grabowski, Alexander Lai, Pedro J. Beltran. This critical, state-of-the-art review brings together the scattered and often controversial information on multidrug resistance reversal. Leading scientists in the field cover P-glycoprotein, the genetics of resistance, and its reversal by drugs...
Categories: Pharmacology, Oncology